Amyloid deposits found in brains of Alzheimer's disease, Down's syndrome and normal aged individuals are composed mainly of aggregated amyloid beta (Ab), soluble form which is a normal protein. We previously reported that soluble Ab (sAb) in normal human plasma and cerebrospinal fluid is complexed to high density lipoprotein (HDL). Consequences of sAb association with the HDL and Ab involvement in the lipid turnover are discussed herein
Cerebrovascular dysfunction significantly contributes to the clinical presentation and pathoetiology...
Background: Plasma amyloid -peptide (A) can compromise the blood-brain barrier, contributing to cere...
Alzheimer's Diseases (AD) is characterized by the accumulation of amyloid deposits of Aβ peptide in ...
Amyloid deposits found in brains of Alzheimer's disease, Down's syndrome and normal aged individuals...
Amyloid deposits found in brains of Alzheimer's disease, Down's syndrome and normal aged individuals...
Cerebrovascular and parenchymal amyloid deposits found in brains of Alzheimer's disease, Down's synd...
Cerebrovascular and parenchymal amyloid deposits found in brains of Alzheimer's disease, Down's synd...
We report studies of the interaction of Alzheimer's amyloid beta protein (Aβ) with normal human plas...
Recently we reported that the soluble form of amyloid beta protein (sAβ) in normal human plasma and ...
AbstractLipids play an important part as risk or protective factors for Alzheimer's disease. This re...
Aggregation of amyloid-beta (Aβ) peptide is the major event underlying neuronal damage in Alzhe...
High-density lipoproteins (HDLs) are complex, heterogenous lipoprotein particles, consisting of a la...
BACKGROUND: The link between cholesterol and Alzheimer's disease (AD) has received much attention, a...
Alzheimer's disease is the principal cause of dementia throughout the world and the fourth cause of ...
Disturbances of the cholesterol metabolism are associated with Alzheimer's disease (AD) risk and rel...
Cerebrovascular dysfunction significantly contributes to the clinical presentation and pathoetiology...
Background: Plasma amyloid -peptide (A) can compromise the blood-brain barrier, contributing to cere...
Alzheimer's Diseases (AD) is characterized by the accumulation of amyloid deposits of Aβ peptide in ...
Amyloid deposits found in brains of Alzheimer's disease, Down's syndrome and normal aged individuals...
Amyloid deposits found in brains of Alzheimer's disease, Down's syndrome and normal aged individuals...
Cerebrovascular and parenchymal amyloid deposits found in brains of Alzheimer's disease, Down's synd...
Cerebrovascular and parenchymal amyloid deposits found in brains of Alzheimer's disease, Down's synd...
We report studies of the interaction of Alzheimer's amyloid beta protein (Aβ) with normal human plas...
Recently we reported that the soluble form of amyloid beta protein (sAβ) in normal human plasma and ...
AbstractLipids play an important part as risk or protective factors for Alzheimer's disease. This re...
Aggregation of amyloid-beta (Aβ) peptide is the major event underlying neuronal damage in Alzhe...
High-density lipoproteins (HDLs) are complex, heterogenous lipoprotein particles, consisting of a la...
BACKGROUND: The link between cholesterol and Alzheimer's disease (AD) has received much attention, a...
Alzheimer's disease is the principal cause of dementia throughout the world and the fourth cause of ...
Disturbances of the cholesterol metabolism are associated with Alzheimer's disease (AD) risk and rel...
Cerebrovascular dysfunction significantly contributes to the clinical presentation and pathoetiology...
Background: Plasma amyloid -peptide (A) can compromise the blood-brain barrier, contributing to cere...
Alzheimer's Diseases (AD) is characterized by the accumulation of amyloid deposits of Aβ peptide in ...